Activist investor Starboard Value accused Pfizer of pressuring its former CEO Ian Read and ex-CFO Frank D’Amelio to halt ...

Pfizer is facing a messy showdown this week after an outside bid to revive the company’s post-Covid share plunge took an ...

Starboard has accused Pfizer of “coercive conduct” after executives who initially backed the hedge fund retracted their ...

Starboard Value alleged that Pfizer officials threatened legal action against two former top executives who had been working ...

The ongoing corporate battle between Pfizer and activist investment firm Starboard Value escalated on Thursday when Starboard ...

In another twist to the tale of Starboard Value's push for change at Pfizer, the activist investor has claimed former ...

The corporate clash between Pfizer and Starboard Value heated up on Thursday when the activist investment firm pressed the ...

That activist investor is veteran corporate gadfly Starboard Value, which made its letter public just before market open. In it, Starboard confirmed its status as a Pfizer shareholder and, as the ...

GSK shares rose after the British drug major agreed to pay up to $2.2 billion to settle thousands of U.S. lawsuits over claims its discontinued heartburn medicine Zantac caused cancer. Write to Rob ...

Starboard has amassed a stake worth about $1 billion, according to The Wall Street Journal, and is pressuring the firm to ...

As the battle over Pfizer’s future continues, former executives said they would no longer support activist investor Starboard ...

Pfizer Inc.'s stock dipped 2.5% Thursday as the company's battle with activist shareholder Starboard Value heated up, after two former executives for the pharma giant said they would not support ...